A comprehensive analysis of 30 preclinical studies found that GLP-1 receptor agonists like semaglutide effectively target Alzheimer's biological mechanisms.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Weight-loss drugs could tackle Alzheimer's—study
30 Preclinical studies reviewed
4 Types GLP-1 drugs examined
Semaglutide, Liraglutide, Exenatide, Dulaglutide Drug classes tested
4 GLP-1 Receptor Agonists drugs evaluated
30 Preclinical Studies studies analyzed